current
molecular
method
detect
avian
human
metapneumoviru
ampv
hmpv
specif
target
toward
viru
speci
individu
subgroup
broad
rang
sybr
green
real
time
rtpcr
develop
amplifi
highli
conserv
fragment
sequenc
n
open
read
frame
method
suffici
effici
specif
detect
mpv
valid
accord
nf
norm
four
ampv
subgroup
estim
low
limit
detect
copi
similar
detect
level
describ
previous
real
time
rtpcr
target
specif
subgroup
rna
virus
present
challeng
design
durabl
molecular
diagnost
test
due
rate
chang
genom
sequenc
vari
substanti
differ
area
time
fact
region
sequenc
primer
hybrid
describ
method
remain
suffici
conserv
sinc
ampv
hmpv
diverg
give
best
chanc
continu
detect
current
subgroup
potenti
unknown
futur
emerg
mpv
strain
metapneumovirus
recent
classifi
new
famili
pneumovirida
genu
metapneumoviru
mpv
afonso
et
al
subdivid
avian
human
strain
speci
virus
caus
import
respiratori
diseas
cook
gough
et
al
picault
et
al
toquin
et
al
van
den
hoogen
et
al
william
et
al
respiratori
diseas
retrospect
report
caus
avian
metapneumoviru
ampv
first
describ
turkey
south
africa
late
shortli
europ
franc
uk
earli
today
ampv
detect
region
world
except
australasia
jone
rautenschlein
human
metapneumovirus
hmpv
first
detect
netherland
shown
circul
sinc
van
den
hoogen
et
al
also
detect
worldwid
major
caus
bronchiol
respiratori
infect
infant
elderli
immunocompromis
adult
falsey
et
al
van
den
hoogen
et
al
date
four
ampv
subgroup
describ
base
genet
antigen
variat
alvarez
et
al
bayonauboy
et
al
juhasz
easton
subgroup
b
virus
present
countri
around
world
except
north
america
australia
naylor
et
al
subgroup
c
virus
report
north
america
senn
et
al
franc
china
korea
lee
et
al
wei
et
al
subgroup
far
detect
franc
bayonauboy
et
al
hmpv
four
genet
lineag
describ
also
base
antigen
genet
variabl
hmpv
subgroup
appear
even
distribut
worldwid
cocircul
given
locat
schildgen
et
al
mpv
isol
difficult
carri
viru
excret
short
infect
often
recogn
bacteri
superinfect
occursoften
viru
clear
laboratori
method
viru
isol
time
consum
labourintens
result
mpv
infect
best
detect
routin
use
either
serolog
molecular
pcr
test
combin
two
method
use
often
decid
accord
sampl
time
exampl
test
enzym
link
immunosorb
assay
elisa
viru
neutral
assay
eterradossi
et
al
van
den
hoogen
et
al
wyeth
et
al
detect
antibodi
elicit
mpv
infect
use
case
infect
suspect
sampl
perform
long
viru
clear
howev
molecular
pcr
test
favour
sampl
respiratori
oropharyng
swab
collect
infecti
period
molecular
assay
gener
sensit
allow
sequencebas
subgroup
viral
rna
sever
convent
mpv
rtpcr
bayonauboy
et
al
cavanagh
et
al
huck
et
al
mackay
et
al
real
time
rtpcr
use
fluoresc
oligonucleotid
probe
taqman
probe
molecular
beacon
probe
cecchinato
et
al
guioni
et
al
jokela
et
al
kwon
et
al
maertzdorf
et
al
velayudhan
et
al
intercal
dye
sybr
green
franzo
et
al
develop
ampv
hmpv
high
sensit
specif
howev
real
time
rtpcr
test
current
exist
detect
known
ampv
one
test
describ
capabl
detect
member
genu
metapneumoviru
assay
would
prove
use
exclud
unknown
ampv
hmpv
subgroup
current
exist
emerg
futur
develop
broadspectrum
test
highli
conserv
region
genom
ampv
hmpv
within
hmpv
n
gene
use
detect
four
hmpv
sublineag
maertzdorf
et
al
ndnx
primer
describ
pan
ampv
detect
ampv
need
identifi
paper
describ
develop
sybr
green
singl
reaction
real
time
rtpcr
detect
member
genu
metapneumoviru
target
region
genom
pcr
select
n
open
read
frame
orf
mpv
two
real
time
rtpcr
use
sybr
green
develop
one
specif
mpv
one
specif
hous
keep
gene
deshydrogenas
gapdh
use
endogen
non
target
control
pcr
valid
accord
associ
de
normalis
afnor
nf
norm
rna
transcript
produc
vitro
valid
rtpcr
refer
ampv
strain
use
valid
complet
method
primer
evalu
silico
use
oligoanalys
tool
http
wwwidtdnacom
secondari
structur
self
heterodim
specif
investig
primerblast
avail
mpv
n
gene
sequenc
genbank
databas
download
access
number
list
align
use
togeth
sever
inhous
sequenc
base
highli
conserv
region
primer
mpv
defin
tabl
two
forward
primer
use
maxim
hybrid
varieti
gapdh
sequenc
download
genbank
databas
access
number
list
align
use
base
conserv
region
primer
pair
pangapdh
forward
revers
defin
tabl
assess
inclus
assay
ampv
field
strain
tabl
compos
eight
subgroup
eleven
subgroup
b
seven
subgroup
c
two
subgroup
virus
toquin
et
al
toquin
et
al
plu
three
attenu
vaccin
strain
two
subgroup
one
b
use
virus
propag
vero
cell
one
refer
strain
subgroup
select
evalu
sensit
method
b
c
titr
tcid
ml
respect
six
hmpv
clinic
sampl
collect
franc
human
patient
nasopharyng
swab
univers
transport
medium
copan
compos
three
subgroup
one
subgroup
also
use
assess
exclus
assay
three
human
respiratori
syncyti
virus
hrsv
classifi
within
famili
pneumovirida
two
serotyp
one
serotyp
b
avian
nonampv
virus
use
latter
compos
avian
paramyxoviru
orthomyxoviru
fowl
adenoviru
reoviru
infecti
bronchiti
viru
turkey
coronaviru
turkey
haemorrhag
enter
viru
infecti
bursal
diseas
viru
serotyp
ii
avian
encephalomyel
viru
list
virus
previous
propag
specif
pathogen
free
spf
chicken
turkey
egg
cell
cultur
fourteen
tracheal
swab
tabl
taken
spf
turkey
duck
previou
experiment
infect
two
speci
ampv
b
c
tabl
taken
accord
protocol
whitworth
et
al
howev
swab
collect
ml
cell
cultur
medium
oppos
viral
transport
media
memh
themo
fischer
scientif
franc
villebon
supplement
penicillinstreptomycin
amphoterin
b
experiment
infect
perform
accord
previous
report
protocol
approv
author
institut
ethic
committe
ling
et
al
rna
extract
use
avian
sampl
qiaamp
viral
rna
mini
kit
qiagen
franc
le
uli
use
human
sampl
high
pure
rna
isol
kit
roch
germani
mannheim
accord
manufactur
instruct
respect
rna
transcript
ampv
subgroup
produc
determin
limit
detect
lod
rtpcr
vitro
transcript
reaction
use
synthes
rna
transcript
dna
templat
use
promot
system
viral
rna
extract
revers
transcrib
superscript
ii
invitrogen
franc
illkirch
min
min
accord
manufactur
recommend
use
primer
subgroup
b
subgroup
c
subgroup
tabl
fig
step
cdna
amplifi
subgroupspecif
forward
primer
ampva
b
c
dtfwd
tabl
incorpor
polymeras
recognit
sequenc
immedi
end
revers
primer
ampva
b
c
dtrev
respect
tabl
fig
step
pcr
reaction
carri
use
expand
high
fidel
pcr
system
roch
diagnost
franc
meylan
accord
manufactur
instruct
amplicon
separ
agaros
gel
min
v
dna
extract
agaros
gel
use
minelut
gel
extract
kit
qiagen
franc
le
uli
quantifi
qubit
fluoromet
life
technolog
franc
saint
aubin
vitro
transcript
use
ng
dna
templat
done
h
use
larg
scale
rna
product
system
promega
franc
product
treat
twice
u
dnasei
rnasefre
dnase
set
qiagen
francel
uli
remov
templat
dna
purif
rna
transcript
perform
use
rneasi
mini
kit
qiagen
franc
le
uli
follow
quantif
use
qubit
rna
concentr
convert
number
molecular
copi
use
follow
formula
one
step
real
time
rtpcr
mpv
gapdh
carri
use
power
sybr
green
kit
appli
biosystem
saint
aubin
franc
final
volum
reaction
mixtur
made
master
mix
enzym
mix
revers
transcriptas
taq
dna
polymeras
rna
templat
either
combin
panmpv
final
concentr
respect
mpv
target
pangapdhfwd
rev
final
concentr
gapdh
target
rtpcr
cycl
use
target
follow
min
revers
transcript
min
cycl
follow
melt
curv
analysi
step
defin
softwar
appli
biosystem
analys
cycl
threshold
ct
melt
temperatur
tm
perform
use
appli
biosystem
softwar
lod
determin
experiment
prepar
serial
dilut
refer
materi
either
rna
transcript
dilut
rnase
free
water
assess
lod
rtpcr
uniqu
virus
dilut
supernat
spf
turkey
tracheal
swab
assess
complet
method
lod
rtpcr
eight
replic
tenfold
serial
dilut
three
separ
assay
perform
lod
complet
method
four
repeat
tenfold
dilut
point
two
separ
assay
perform
ampv
subgroup
b
c
refer
virus
lod
consid
last
posit
dilut
gave
specif
amplif
confid
level
cycl
threshold
ct
melt
temperatur
tm
analys
cut
valu
set
ct
appli
repeat
assay
evalu
calcul
ct
mean
valu
standard
deviat
sd
coeffici
variat
cv
replic
within
assay
intraassay
variabl
separ
assay
interassay
variabl
either
log
number
rna
copi
per
infecti
viru
titr
express
tissu
cultur
infecti
dose
tcid
ml
plot
ct
follow
equat
ax
b
use
slope
regress
line
pcr
effici
calcul
formula
e
x
amplif
effici
correspond
slope
consid
accept
agreement
nf
norm
linear
evalu
express
coeffici
determin
r
linear
regress
curv
r
broeder
et
al
concentr
rna
transcript
ampv
b
c
respect
concentr
adjust
lod
studi
ampv
belong
subgroup
b
c
posit
ct
valu
obtain
subgroup
subgroup
b
subgroup
c
subgroup
tabl
tm
analysi
show
mean
valu
sd
n
subgroup
sd
n
subgroup
b
sd
n
subgroup
c
sd
n
subgroup
tabl
hmpv
belong
subgroup
posit
ct
valu
vari
subgroup
subgroup
b
tabl
rna
templat
isol
nonmpv
strain
spf
turkey
duck
tracheal
swab
noninfect
vero
cell
neg
except
two
three
hrsv
sampl
gave
posit
ct
valu
close
detect
threshold
mpv
sensit
method
shown
equal
specif
housekeep
gene
gapdh
detect
case
sampl
ct
observ
mean
tm
valu
sd
n
tabl
rtpcr
standard
curv
ampv
standard
curv
subgroup
gener
plot
ct
fig
product
dsdna
use
templat
invitro
transcript
step
revers
transcript
reaction
superscript
ii
use
primer
specif
subgroup
step
pcr
reaction
expand
high
fidel
enzym
use
forward
primer
specif
subgroup
incorpor
promot
recognit
sequenc
immedi
revers
primer
specif
subgroup
valu
log
copi
rna
transcript
log
tcid
ml
viral
titer
fig
standard
curv
rna
transcript
exhibit
highli
linear
correl
subgroup
subgroup
r
subgroup
b
r
subgroup
c
r
subgroup
r
fig
standard
curv
refer
virus
also
highli
linear
correl
subgroup
tcid
ml
r
subgroup
b
tcid
ml
r
subgroup
c
tcid
ml
r
subgroup
tcid
ml
r
fig
rtpcr
effici
subgroup
calcul
use
equat
regress
line
rna
transcript
effici
subgroup
subgroup
b
subgroup
c
subgroup
observ
fig
refer
virus
effici
subgroup
subgroup
b
subgroup
c
subgroup
observ
fig
lod
rna
transcript
subgroup
b
c
consid
respect
tabl
repres
last
dilut
point
gave
posit
specif
amplif
lod
viral
rna
subgroup
b
c
consid
tcid
ml
respect
tabl
repres
last
dilut
point
gave
posit
specif
amplif
result
mean
ct
valu
well
sd
cv
valu
estim
intraand
interassay
variabl
summar
tabl
rna
transcript
viral
rna
rang
cv
uniform
regardless
subgroup
quantiti
assay
test
rna
transcript
intraassay
variabl
subgroup
subgroup
b
subgroup
c
subgroup
interassay
variabl
subgroup
subgroup
b
subgroup
c
subgroup
viral
rna
intraassay
variabl
subgroup
subgroup
b
subgroup
c
subgroup
interassay
variabl
subgroup
subgroup
b
subgroup
c
subgroup
rna
templat
isol
tracheal
swab
taken
turkey
infect
ampv
b
usc
duck
infect
frampv
c
posit
mpv
gapdh
rna
templat
isol
tracheal
swab
spf
turkey
duck
posit
gapdh
detect
demonstr
characterist
amplif
dissoci
curv
data
shown
ct
tm
valu
report
tabl
metapneumovirus
subdivid
avian
human
strain
although
phylogenet
analysi
shown
avian
subgroup
c
virus
close
relat
human
virus
avian
virus
b
reason
may
clearer
consid
ampv
b
type
metapneumovirus
ampv
c
hmpv
type
ii
previous
suggest
brown
et
al
molecular
relationship
hmpv
ampvc
led
hypothesi
virus
could
gener
cross
speci
barrier
de
graaf
et
al
possibl
mpv
cross
speci
barrier
differ
anim
host
speci
prompt
search
region
sequenc
suffici
conserv
across
member
genu
metapneumoviru
develop
panmpv
real
time
rtpcr
discuss
paper
region
target
previous
type
test
resid
n
orf
maertzdorf
et
al
toquin
et
al
due
high
nucleotid
conserv
proxim
viral
genom
gene
closer
mpv
like
virus
order
mononegaviral
report
greater
abund
infect
cell
due
transcript
strategi
thu
increas
chanc
detect
viral
rna
molecul
collin
karron
studi
short
length
sequenc
nucleotid
n
orf
mpv
deem
suffici
conserv
develop
sybr
green
real
time
rtpcr
howev
mixtur
three
primer
two
forward
sens
one
revers
requir
obtain
balanc
result
across
four
ampv
subgroup
sybr
green
technolog
chosen
taqman
approach
latter
technolog
requir
three
zone
conserv
sequenc
one
e
lemaitr
et
al
journal
virolog
method
primer
plu
anoth
insid
region
amplifi
fluoresc
probe
region
sequenc
found
mpv
genom
addit
amplif
dna
molecul
use
intercal
dye
sybr
green
measur
term
ct
valu
also
exploit
melt
curv
valu
assess
end
amplif
process
therefor
peak
locat
melt
curv
depend
sequenc
gcat
ratio
length
result
amplicon
riri
et
al
case
tm
valu
statist
differ
use
identifi
separ
subgroup
even
pcr
specif
design
broad
rang
current
studi
possibl
use
tm
valu
differenti
viru
speci
among
ampv
hmpv
subgroup
method
shown
specif
highli
sensit
mpv
test
two
virus
amongst
nonmpv
virus
give
posit
signal
near
limit
cut
threshold
furthermor
two
virus
hrsv
strain
belong
genu
orthopneumoviru
share
famili
mpv
experi
ongo
check
whether
orthopneumovirus
could
also
detect
regard
sensit
later
respons
observ
ct
hmpv
b
sublineag
compar
result
obtain
rest
mpv
test
later
respons
may
explain
presenc
mismatch
seventh
nucleotid
primer
end
hmpv
b
sequenc
also
possibl
hmpv
b
clinic
sampl
contain
pcr
inhibitor
hmpv
sampl
although
similar
result
obtain
gapdh
hous
keep
gene
b
lineag
would
suggest
otherwis
method
valid
use
ampv
rna
transcript
refer
virus
four
ampv
subgroup
show
high
linear
effici
lowest
r
equal
rtpcr
addit
signal
high
repeat
four
ampv
subgroup
within
concentr
rang
test
ampv
b
c
respect
tabl
final
lod
rang
demonstr
broad
rang
rtpcr
equal
sensit
detect
ampv
qrtpcr
design
specif
ampv
subgroup
guioni
et
al
summari
sybr
green
rtpcr
pan
mpv
develop
valid
high
specif
sensit
effici
repeat
method
broadspectrum
detect
format
use
applic
screen
mpv
infect
particularli
ampv
larg
scale
onfarm
epidemiolog
studi
detect
minim
diagnost
cost
mpv
undetermin
subgroup
assign
